REQUEST A DEMO
Total
USD $0.00
Search more companies

Lanzhou Foci Pharmaceutical Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lanzhou Foci Pharmaceutical Co.,Ltd. Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Lanzhou Foci Pharmaceutical Co., Ltd. is a national high-tech enterprise that specializes in the research, manufacturing, and sales of traditional Chinese medicine. The company has been recognized as a key participant in the National Torch Program. With 186 products listed in the national medical insurance catalog, including 10 premium products and 4 high-quality and affordable products, Lanzhou Foci Pharmaceutical Co., Ltd. has established a strong presence in the market. Their products, such as Dingxuan Pills and Canrong Guben Haoshao Pills, are protected as second-level traditional Chinese medicine varieties. The company's Baolu and Minshan brand concentrated pills have been awarded the title of "Lanzhou Fine Products." The "Foci" brand is a well-known Chinese time-honored brand and a renowned trademark, enjoying high recognition and market acceptance both domestically and internationally. The company's "Minshan" trademark for export products has been registered in more than 20 countries and regions worldwide. Lanzhou Foci Pharmaceutical Co., Ltd. has obtained certifications from organizations such as the Therapeutic Goods Administration of Australia and the Ministry of Health, Labour and Welfare of Japan, making it one of the Chinese pharmaceutical companies with the most foreign drug certifications.

Headquarters
No. 2289, Huashan Road, Lanzhou New District, Lanzhou City, Gansu Province
Lanzhou; Gansu; Postal Code: 730000

Contact Details: Purchase the Lanzhou Foci Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.fczy.com

Basic Information
Total Employees:
Purchase the Lanzhou Foci Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Lanzhou Foci Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Lanzhou Foci Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Lanzhou Foci Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
June 28, 2000
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
61.63%
Purchase this report to view the information.
0.8%
Purchase this report to view the information.
0.56%
Purchase this report to view the information.
0.54%
Purchase this report to view the information.
0.54%
Subsidiaries
Gansu Foci Chinese Medicinal Materials Management Co., Ltd.
100%
Lanzhou Foci Bioanalytical Testing Co., Ltd.
100%
Lanzhou Foci Health Industry Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Lanzhou Foci Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-17.66%
Total operating revenue
-18.53%
Operating profit (EBIT)
-38.44%
Net Profit (Loss) for the Period
-31.48%
Total assets
-3.53%
Total equity
1.47%
Operating Profit Margin (ROS)
-2.2%
Net Profit Margin
-1.15%
Return on Equity (ROE)
-1.09%
Debt to Equity Ratio
-0.33%
Quick Ratio
0.2%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?